Observe Medical ASA: Notice of extraordinary general meeting on 10 October 2025 in connection with private placement

Oslo, 19 September 2025

Reference is made to the announcement made by Observe Medical ASA (the"Company"or "Observe Medical", OSE ticker "OBSRV") on 16 September 2025, regarding theentry into of an investment agreement with Songa Capital AS (the "InvestmentAgreement"). Pursuant to the Investment Agreement, Observe Medical will issue20million new shares to Songa Capital AS and other companies affiliated with theBlystad group at a subscription price of NOK 0.50 per share, raising totalgrossproceeds of NOK 10 million (the "Private Placement"). The Private Placement isconditional upon the approval by the extraordinary general meeting of thesharecapital increase pertaining til the Private Placement.

An extraordinary general meeting of the Company will be held on 10 October2025at 11:00 (CEST) (the "EGM"). The notice of the EGM, including agenda, proposedresolutions, registration form, a form of proxy and other relevant documents,isenclosed hereto.

As set out in the agenda for the EGM, the board of directors of the Companyproposes that the general meeting resolves to increase the Company's sharecapital by NOK 8,400,000 through the issuance of 20,000,000 new shares tocomplete the Private Placement.

This information is subject to the disclosure requirements in section 5-12 ofthe Norwegian Securities Trading Act.

For further information, please contact:

Jørgen Mann, CEO Observe Medical

Mobile: +45 408 67 558

E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical

Mobile: +47 958 12 765

E-mail: johan.fagerli@observemedical.com

About Observe Medical:

Observe Medical is a Nordic medtech company that develops, markets and sellsinnovative medtech products for the global market. The Company is committed toimproving patient welfare and patient outcomes, improving clinical dataaccuracyand promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales andcommercialisation of its broad portfolio of medical technology products,mainlyin urine measurement and ultrasound, in combination with targeted M&A anddistribution. Observe Medical is working with a network of leadingdistributorsto provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.

https://newsweb.oslobors.no/message/655785